OR WAIT null SECS
April 23, 2025
Article
The findings may facilitate accurate diagnoses, which could help patients slow or stop permanent hair loss.
April 19, 2025
Our top 5 headlines spotlight FDA approvals for maralixibat and dupilumab, plus key trial results in diabetes, cardiovascular disease, and retinal vein occlusion.
April 15, 2025
This network meta-analysis compares the relative effectiveness and safety of different monotherapies for patients living with alopecia areata.
Side effects of baricitinib were well within safety parameters, indicating the drug’s viability as a alopecia treatment for adults.
This systematic review highlights current research on ruxolitinib’s off-label use in dermatology, specifically for conditions such as alopecia and psoriasis.
April 14, 2025
These data on 5α-reductase inhibitors highlight impacts on patients with benign prostatic hyperplasia or androgenic alopecia.
April 11, 2025
This analysis demonstrates the effectiveness of methotrexate application via microinfusion in frontal fibrosing alopecia.
April 10, 2025
These data highlight the potential impacts of baricitinib across significant hair-bearing areas involved in alopecia areata.
This retrospective, real-world analysis highlights several notable findings on JAK inhibitor use among patients with alopecia areata.
April 07, 2025
Video
This episode of the SOCS podcast features an in-depth discussion between Crystal Aguh, MD, and John Harris, MD, PhD.
